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Abstract. The purpose of this study was to identify
the binding site(s) within laminin for the a3ß, integrin
receptor. It has been previously shown, using proteo-
lytic fragments and anti-laminin antibodies, that the
region in laminin for a3ß, integrin binding is localized
to the carboxy-terminal region at the end of the long
arm (Gehlsen, K. R., E. Engvall, K. Dickerson,
W. S. Argraves, and E . Ruoslahti. 1989. J. Biol.
Chem. 264 :19034-19038; Tomaselli, K . J., D. E.
Hall, L. T. Reichardt, L. A. Flier, K. R. Gehlsen,
D. C. Turner, and S. Carbonetto. 1990. Neuron.
5:651-662) . Using synthetic peptides, we have
identified an amino acid sequence within the carboxy-
terminal region of the laminin A chain that is recog-
nized by the a3ß1 integrin. The amino acid se-
quence represented by the synthetic peptide GD-6
(KQNCLSSRASFRGCVRNLRLSR residues numbered
3011 to 3032) of the globular domain of the murine A
chain supports cell attachment and inhibits cell adhe-
AMJNIN is a multifunctional basement membrane glyco-
protein that has been shown to promote the attach-
ment and migration of cellsand to participate in cel
lular differentiation and tumor metastasis (Chung et al .,
1979; Terranova et al., 1983; Goodman et al., 1987) . In-
teractions of cells with laminin have been shown to be medi-
ated by both integrin-type cell surface receptors (Hemler et
al., 1987; Gehlsen et al., 1989; Sonnenberg et al., 1988; Ig-
natius et al., 1990) and by other nonintegrin molecules in-
cluding a 67-kD protein (Malinoff and Wicha, 1983; Wewer
et al ., 1987) and 01,4 galactosyltransferase (Begovac et al .,
1991) .
Integrins are a family of cell surface transmembrane
receptors involved in the attachment and migration of cells
on various extracellular matrix proteins and participate in
cell-cell interactions (Hynes, 1987; Hemler, 1990; Ruo-
slahti, 1991). Several integrins are known to be receptors for
laminin including a,ß,, a2ß,, a3ß1 , a6ß,, a7ß, (Tomaselli et
al., 1990; Languino et al., 1989; Gehlsen et al., 1989; Son-
nenberg et al., 1988, 1991; Kramer et al., 1991), and a4ß3
(Sonnenberg et al., 1990; Kramer et al ., 1990). In addition,
the a,ß,, a2ß,, and a3ß, integrins also bind to other ex-
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sion to laminin-coated surfaces. By affinity chroma-
tography, peptide GD-6-Sepharose specifically bound
solubilized a3ß, from extracts of surface-iodinated
cells in a cation-dependent manner, while it did not
bind other integrins. In addition, exogenous peptide
GD-6 specifically eluted bound a3ß, from laminin-
Sepharose columns but did not elute the 01501 integrin
from a fibronectin-Sepharose column. Using integrin
subunit-specific monoclonal antibodies, only those an-
tibodies against the a3 and ß, subunits inhibited cell
adhesion to peptide GD-6-coated surfaces. Finally, a
polyclonal antibody made against peptide GD-6
reacted specifically with both murine and human lami-
nin and significantly inhibited cell adhesion to
laminin-coated surfaces but not those coated with
other matrix proteins. These results identify the lami-
nin A chain amino acid sequence of peptide GD-6 as
representing a binding site in laminin for the a3ß1
integrin.
tracellular matrix proteins such as fibronectin and collagens
(Hemler, 1990; Ruoslahti et al ., 1991). However, well-
defined binding sites within laminin for the various laminin-
binding integrins have not yet been characterized.
Several regions in laminin for integrin binding have been
identified using antibodies and proteolytic fragments of
laminin. The region in laminin for a,ß, binding has been
localized to the murine laminin fragment PI, which is com-
prised of the intersection of the cross-region of laminin con-
taining the A, BI, and B2 chains (Tomaselli et al., 1990), and
a,.ß3 has been shown to recognize the cryptic RGD site
within the A chainof the Pl fragment (Clement et al., 1990;
Kramer et al ., 1990; Tashiro et al ., 1991). a6,ß, has been
shown to interact with the murine laminin fragment E8
which is comprised of the carboxy-terminal domain (Son-
nenberg et al., 1990, 1991) . Previous work on a3ß, has in-
dicated that the binding site within laminin is located in the
carboxy-terminal region at the end of the long arm (Gehlsen
et al., 1989; Tomaselli et al., 1990). This conclusion was
based on results showing that purified a3ß, bound to a
chymotrypsin fragment of human laminin which is similar
to the murine E8 fragment, and that antibodies whose deter-
449minants map to the carboxy-terminal domain ofhumanlami-
nin pepsin fragment (Engvall et al ., 1986; Dillner et al .,
1988) inhibit purified a3ß, receptor binding to intact hu-
man laminin (Gehlsen et al., 1989). These results have also
been confirmed using a neuronal cell line with proteolytic
fragments ofmurine laminin and antibodies specific for inte-
grin subunits (Tomaselli et al., 1990) .
Recently, several synthetic peptides derived from the
amino acid sequence of the murine laminin A, Bl, and B2
chains have been described that mimic certain functional ac-
tivities of intact laminin (Graf et al., 1987; Charonis et al.,
1988; Tashiro et al., 1989; Skubitz et al., 1990, 1991) . In-
terestingly, only a peptide containing an RGD sequence from
the A chain near the cross region has been shown to inter-
act with an integrin receptor, a.ß3 (Tashiro et al., 1991;
Kramer et al., 1990). Skubitz et al. (1991) has described two
synthetic peptides derived from the carboxy-terminal globu-
lar domain (G domain) of the murine laminin A chain that
may interact with a ß, integrin. However, the precise
identification of a laminin-binding integrin involved in this
interaction has not yet been determined.
The present study was undertaken in an effort to map the
location of the binding site(s) within laminin for the a3ß,
integrin. These studies were done by using synthetic peptides
derived from the carboxy-terminal globular domain region
of the murine Engelbreth-Holm-Swarm (EHS)'-laminin A
chain in conjunction with cell adhesion assays, receptor
binding assays, peptide affinity chromatography of solubi-
lized cell membranes, and antiintegrin antibodies. We report
herein on the identification of a contiguouspeptide sequence
within laminin that is capable of binding the a3ß, integrin.
This amino acid sequence likely represents at least one bind-
ing site in laminin for this receptor.
Materials and Methods
CellLines
The human melanoma cell line C8161 was kindly provided by Dr. Mary
J. C. Hendrix, University ofArizona, Tucson, AZ(Bregmanand Meyskens,
1983; Welch et al., 1991). The MG-63 (human osteosarcoma) and the
IMR-90 cells (human fetal fibroblasts) werepurchased fromthe Amer. Type
Culture Collection (Rockville, MD). All cell lines were cultured in DME
supplemented with 10% FCS and 0.1% gentamicin (Sigma Chem. Co., St.
Louis, MO). Cells were harvested using cation-free PBS containing 2 mM
EDTA.
Antibodies
mAbs reactive toward specific integrin subunits were used for immunopre-
cipitations and for inhibition of cell attachment. Antibodies PIH5 (anti-
a2), PIB5 (anti-a3), P4G9 (anti-CO, PID6 (anti-a5), and P4C10 (anti-ßi)
were either purchased from Telios Pharmaceuticals Inc. (LaJolla, CA) or
generously provided by Dr. Elizabeth Wayner (Carter et al., 1990). Dr.
Arnoud Sonnenberg donated rat mAb GOH3 (anti-a6; Sonnenberg et al .,
1988), Dr. David Cheresh kindly provided mAbs LM609 (anti-a,,ß3) and
LM142 (anti-av) (Cheresh et al ., 1987), Dr. Erkki Ruoslahti donated mAb
LM442 (anti-ß, ; Cheresh, D., and E. Ruoslahti, unpublished results),
mAbs 60.3 and 1134 (both anti-ßz) were from Dr. Arfors (Beatty et al.,
1983; Wright et al., 1983).
Polyclonal antibodies were generated against the synthetic peptides cou-
pled to the carrier protein, keyhole limpet hemocyanin, as previously de-
scribed (Skubitz et al., 1990). Briefly, rabbits were immunized with the
peptides-keyhole limpet hemocyanin, and sera was tested for specificity by
ELISA on immobilized peptide or on murine EHS-laminin. IgG was
1. Abbreviation used in this paper: EHS, Engelbreth-Holm-Swarm.
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purified by ammonium sulfate precipitation and DEAE chromatography.
Purity of IgG was determined by SDS-PAGE and subsequent ELISA. In ad-
dition, peptide GD-6-specific polyclonal antibodies were affinity purified
by chromatography on EHS-laminin-Sepharose as described previously
(Skubitz et al., 1990).
PeptideSynthesis
A series ofpeptides were synthesized from both the A and BI chains oflami-
nin in the region ofthe carboxy-terminal portion of the long arm (Fig. 1),
since the a30, integrin has been shown to bind to this domain (Gehlsen et
al., 1989; Tomaselli et al., 1990). The criteria for peptide selection was
based on the net positive charge and hydrophilicity of specific regions of
murine EHS-laminin such that the laminin-derived peptides would have an
increased potential for cell surface interactions. Peptide sequences were de-
rived from the published sequences of the EHS-laminin A and BI chains
(Sasaki et al., 1988) and synthesized by the Merrifield solid-phase method
as previously described (Charonis et al ., 1988). Peptides were purified by
HPLC and verified by amino acid analysis using an amino acid analyzer
(Beckman Instrs., Inc., Fullerton, CA) and sequence determination done
by sequential Edman degradation on a gas phase sequenator. Peptides con-
taining free sulthydryl groups were deblocked during the process of the
removal of the peptides from the resin using hydrofluoric acid and acetic
acid. In addition, sulthydryl groups in several of the peptides were treated
by alkylation (Kouzi-Koliakos et al., 1989).
Radiolabeling ofCellSurface Proteins
andImmunoprecipitations
Cells were surface labeled with "I as previously described (Gehlsen et
al., 1988, 1989). Briefly, 100 U lactoperoxidase/ml (Sigma Chem. Co.),
1 MCi/m1 1251 (New England Nuclear, Burbank, CA), and 4 pl of a 30%
solution of hydrogen peroxide were added to 101 cells for 10 min on ice.
Unbound 1151 was removed by sequential washings with PBS and cells were
extracted as described below. Lysates or eluates to be immunoprecipitated
were first preabsorbed with 1 ml of goat anti-mouse IgG-Agarose (Sigma
Chem. Co.). Radioactive counts were determined andequivalent counts in-
cubated with 1 ug each of the various andintegrin antibodies described
above. Goat anti-mouse IgG-Agarose was then added to the mixture and
incubated overnight at 4°C with shaking. For the rat mAb against ab, goat
anti-rat IgG-Agarose was used. The immunocomplexes were centrifuged
and the beads washed five times with extraction buffer (see below) contain-
ing 500 mM NaCl and 1% Tween-20. The ini nunocomplexes were removed
from the Agarose with 4x sample buffer (0.625 M Tris-HCI, pH 6.8, 1%
glycerol, 0.25% SDS, an 0.06% bromophenol blue), boiled for 5 min, and
analyzed by 7.5% SDS-PAGE as previously described (Gehlsen et al.,
1989). Gels were dried and autoradiographed using X-OMAT film (East-
man Kodak Co., Rochester, NY).
CellAdhesion Assays
Cell adhesion to both murine and human laminin, proteolytic fragments,
orchemically synthesized peptides wasdoneaspreviouslydescribed (Wilke
and Skubitz, 1991). Briefly, various concentrations of the proteins or pep-
tides to be immobilized were dissolved in either PBS or a 0.05-M sodium
bicarbonate buffer, pH 8.6. Protein solutions were then added to Immulon
1 plates (Dynatech Labs., Inc., Chantilly, VA) and adsorbed overnight at
room temperature. Plates were then extensively washed with PBS and un-
bound sites blocked with 5 mg/ml BSA or ovalbun3in. Cells were harvested
and the concentration adjusted to 50,000 cells/150 pl. 150-Al aliquots were
added to each well and incubatedat 37°C for 1 h. In the peptide or antiinte-
grin mAb inhibition studies, the cells were preincubated for30 min at 37°C
with the "inhibitorsr, and then both cells and inhibitors were added to the
wells and incubated for an additional hour at 37°C. Plates were washed
three times with PBS and adherent cells were fixed and stained with 3.75%
paraformaldehyde and 0.1% toludine blue. Wells were again washed five
times with PBS and adherentcells were quantitated using a microtiter plate
reader (TiterTec MultiScan Plus; Flow Labs., Inc., McLean, VA) at an ab-
sorbance of 600 nm.
Inhibition ofC8161 cell adhesion to various surfaces with purified IgG
against peptide GD-6 was performed as previously described (Skubitz et
al., 1990). Briefly, 100 A.1 ofDME/Hepes containing2 mg/mlBSA and var-
ious concentrations of the purified IgGs were added to microtiter wells that
had been preadsorbed with 0.35 Ag of laminin, 0.04 Ag of peptide GD-6,
or0.25 kgoffibronectin. TheIgG was incubated inthe wells for 1 hat 37°C.
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Figure 1. Diagrammatic model
oflaminin indicating the loca-
tionofthepeptides . The A, B1,
and B2 chains of laminin are
shown with the globular do-
mains indicated (e) . Other
structural features are not shown
for simplification . Peptides
GD-1, GD-2, GD-3, GD-6,
AG-1, and KRGD are derived
from the A chain of laminin
and peptide F17 is derived
from the Bl chain of laminin .
100 Al of radiolabeled cells at lWlml were added to each well and in-
cubated for 30 min at 37°C, at which time the wells were washed and adher-
ent cells were solubilized and quantitated in a scintillation counter as de-
scribed previously (Charonis et al ., 1988) .
Affinity Chromatography
Peptides were coupled to activated CH-Sepharose according to the
manufacturer's instructions (Pharmacia LKB Biotechnology Inc ., Piscata-
way, NJ) . In addition, a mock-coupled column was made without peptides
for use as a control column . Briefly, 10 mg ofHPLC-purified peptides were
dissolved in coupling buffer (15 mM sodium carbonate and 35 mM sodium
bicarbonate, pH 8.6) and then the peptide solution was added to 3 ml of
preswollen beads and mixed overnight at 4°C. Unbound peptide was re-
moved by washing the beads withcoupling bufferandthe remaining reactive
groups were hydrolyzed at pH 8.0 with 0.1 M Tris-HCl for 2 h . Surface-
iodinated cells were extracted as describedpreviously (Gehlsen et al ., 1988,
1989), using extraction buffer (50mM Tris-HCI, pH 7.4, 50mM octyl-ß-D-
glucopyranoside, 15 mM NaCl, 1 MM MgC12, 1 mM MnC12, and 1 mM
PMSF) . Cleared lysates were then incubated with the various pep-
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tide-Sepharose beads as a slurry with constant mixing overnight at 4°C.
The peptide-Sepharose beads were then packed into a column and the
columns were washed with extraction buffer, and eluted with 20mM EDTA
in extraction buffer lacking the cations . Columns were subsequently eluted
with 1 M NaCl to isolate any remaining bound proteins . Peak elution frac-
tions were then electrophoresed by SDS-PAGE .
Affinity chromatography on Sepharose columns coupled with the pepsin
fragment of human laminin or the cell attachment fragment of fibronectin
was done as previously described elsewhere (Gehlsen et al ., 1988, 1989) .
Radio-receptor BindingAssay
The ability of the various laminin-derived synthetic peptides to support
purified a3ß1 integrin binding was tested in a solid-phase radio-receptor
binding assay as previously described (Gehlsen et al ., 1989) . Briefly,
surface-iodinated C8161 cells were extracted as described above and the
cleared extracts passed over a human laminin-Sepharose column . Purified
a3ß1 was eluted with 20 mM EDTA and the purified receptor verified by
immunoprecipitation with integrin subunit-specific mAbs followed by SDS-
PAGE . The EDTA in the receptor-containing eluate was then neutralized
with 15 MM MgC12 and 15 mM MnC12 . The receptor eluate was adjusted
to 200,000 cpm/150 pl and thenadded to microtiter wells that had beenpre-
viously coated with either 2 pg/ml of human laminin or 0 .5 ug/ml of the
various peptides . The plates were incubated for 2 h at room temperature,
the wells were washed three times with extraction buffer, and the bound
receptor was solubilized in TBS containing 1% SDS. Solubilized receptor
was quantitated by counting receptor-associated radioactivity in a gamma
counter (AutoGamma 5650 ; Packard Instr. Co ., Inc., Meriden, CT) .
Results
Identification ofaSynthetic Peptidefrom theLaminin
A Chain That Supports a3ß, Integrin Binding
We and others have previously determined that a 3ß1 inte-
grin binds on or near the carboxy-terminal region at the end
of the long arm of both murine (EHS) or human laminin
(Gehlsen et al., 1989 ; Tomaselli et al ., 1990 ; Goodman et
al ., 1991 ; Sonnenberg et al ., 1991) . To delineate the binding
site(s) in laminin for a3ß1, we synthesized a series of pep-
tides from this region of laminin. Peptide sequences were
selected for synthesis based on hydrophilicity and net charge
criteria (Table 1), such that these peptides would be predicted
Table L Laminin-derived Peptides, Their Sequences, Location, and Ability to Support a3ß, Integrin Binding
Amino acid sequence designation is based on single letter codes . G, glycine ; A, alanine; V, valine; L, leucine ; I, isoleucine; F, phenylalanine ; Y, tyrosine ;
W, tryptophan ; M, methionine ; C, cysteine ; S, serine ; T, threonine ; H, histidine; K, lysine; R, arginine ; D, aspartate; E, glutamate; N, asparagine ; Q, glutamine ;
P, proline. Sequences were derived from murine EHS-laminin (Sasakiet al ., 1988), except for KRGD, which was derivedfrom the carboxy-terminal human laminin
A chain (Olsen et al ., 1989) . N/A, not applicable.
f Net charge is calculated by assuming a + 1 net charge for lysine (K) and arginine (R) residues, and a net -1 charge for glutamic acid (E) and aspartic acid
(D) at neutral pH . Histidine is assumed to be uncharged at this pH .
§ Calculated by the method of Kyte and Doolittle (1982) . According to this method, more hydrophilic peptides correspond to the more negative numerical values .
II a3ß1 bound represents the percentage of purified a3ß1 bound to peptide-coated surfaces compared with that bound to human laminin-coated wells (100%), as
described in Materials and Methods . N/D, not done.
1 Harvath, L ., N . E . Brownson, and A . P . N . Skubitz . 1991 . Laminin peptides stimulate neutrophil chemokinesis . J. Cell Biol. 115(3, Pt . 2):113a. (Abstr .)
Peptide Amino acid sequence' Location' Net charge* Hydrophilicity4 a3ß1 boundll References
%
GD-1 KATPMLKMRTSFHGCIK 2,615-2,631 (A) +5 -5.1 21 Skubitz et al ., 1991
GD-2 KEGYKVRLDLNITLEFRTTSK 2,890-2,910 (A) +2 -10.1 10 Skubitz et al ., 1991
GD-3 KNLEISRSTFDLLRNSYGVRK 2,443-2,463 (A) +3 -8.6 12 Skubitz et al ., 1991
GD-6 KQNCLSSRASFRGCVRNLRLSR 3,011-3,032 (A) +6 -8.9 79 Wilke et al ., 1991
HGD-6 KQKCLRSQTSFRGCLRKLALIK 3,009-3,030 (A) +7 -9.25 87 N/A
SGD-6 CRNRGRCNSSLFQVRSRKLLSA N/A +6 -8.9 N/D N/A
HSGD-6 KQCLKSQRSFTRGLCRLKAKIL N/A +7 -9.25 N/D N/A
AG-1 KLLISRARKQÁASIK 2,087-2,101 (A) +5 -0 .5 14 Harvath et al .1
F17 LERKYENDQKYLEDKA 1,722-1,737 (BI) -1 -33.9 9 N/A
KRGD VEKRGDREEA 2,515-2,523 (A) -1 N/A 11 N/A-- t
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Peptide GD-6Supports CellAttachment andInhibits
Laminin-mediated CellAdhesion
Figure 2. C8161 melanomacell adhesionto peptide GD-6. Radiola-
beled C8161 cells were incubated for 2 h in microtiter wells ad-
sorbed with various concentrations of peptide GD-6 (m), laminin
(o), or ovalbumin (A). Cell adhesion is expressed as a percentage
of the total number of cells added. Each value represents the mean
of four separate determinations. Three separate experiments gave
similar results.
to be from sites on laminin that would be accessible for the
interaction with cell surface receptors. These peptides were
tested for their ability to support receptor attachment using
a radio-receptor binding assay. Table I lists the results of
these experiments for 7 of the 24 laminin-derived peptides
tested. One peptide, designated GD-6 from murine laminin,
supported the binding of high levels of purified a3ß, . This
peptide is from the carboxy terminus of the EHS-laminin A
chain and has the amino acid sequence KQNCLSSRASFR-
GCVRNLRLSR (Wilke and Skubitz, 1991). Peptide GD-6
and peptide HGD-6 from the homologous region of human
laminin bound purified a3ß1 at a level comparable to 80%
of that which bound to human laminin, suggesting that the
peptide GD-6 sequence represents a major ligand binding
site for the a3ß1 integrin. The other laminin-derived and
control peptides did not significantly support a3ß1 integrin
binding, although, many of the peptides had similar net
cationic charges (Table I).
Peptide GD-6 has previously been shown to directly promote
the attachment of human keratinocytes in a concentration-
dependent manner when used as an adhesion substrate
(Wilke and Skubitz, 1991) . In addition, peptide GD-6 in-
hibits keratinocyte cell attachment to EHS-laminin-coated
substrates (Wilke and Skubitz, 1991). We have extended this
work to human melanoma cells (C8161), human osteosar-
coma cells (MG-63), and human fetal fibroblasts (IMR90),
and have found that peptide GD-6 also supports the adhesion
of these cells. For example, C8161 human melanoma cells
adhered to peptide GD-6 and human laminin in a concentra-
tion-dependent manner (Fig. 2). The cells adhered to surfaces
adsorbed with peptide GD-6 at levels comparable to intact
laminin, with maximal attachment occurring at a coating
concentration of 1 hg per well. Cells did not adhere to oval-
bumin (Fig. 2). The cells adhered to several other laminin-
derived peptides including GD-1 and GD-3 (data not shown)
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Figure 3. Inhibition of C8161 cell adhesion to human laminin by
peptide GD-6. The synthetic peptides were each incubated with
C8161 human melanoma cells at various concentrations for 30 min
before adding the cells in the continued presence of the peptides
into microliter wells as described in Materials and Methods. Data
are expressed as a percentage of the number of cells that adhere to
human laminin in the absence of peptides: GD-3 (o), GD-6 (m),
SGD-6 (o), HSGD-6 (n, upper), F17 (o), and KRGD (A). Data
represent duplicate experiments done in triplicate. Control experi-
ments were done in the absence of peptide (9). SD was <6% for
all groups.
that have previously been described (Skubitz et al., 1991) .
These results suggest that other melanoma cell binding sites
exist in laminin and that other cell surface receptor mecha-
nisms for laminin-mediated adhesion are probably involved.
Peptide GD-6 and several other peptides were then tested
for their ability to inhibit C8161 melanoma cell adhesion to
human laminin-coated surfaces. Peptide GD-6 inhibited cell
attachment to human laminin in a concentration-dependent
manner with maximal inhibition of -80 % observed at a con-
centration of500,ug/ml (Fig. 3) . Peptide GD-3 had a modest
inhibitory effect on cell adhesion (-30% at 500 jAg/ml),
while the laminin-derived RGD-containing peptide (KRGD)
and peptide F17 from the BI chain had only a minimal inhibi-
tory effect at similar or higher concentrations. Control pep-
tides (SGD-6 and HSGD-6) and several other laminin-
derived peptides containing similar net charge and distribu-
tion of charged residues (Table 1) did not significantly inhibit
cell adhesion to human laminin-coated substrates (data not
shown). The inability of peptide GD-6 to completely inhibit
cell adhesion is most likely due to the presence of other do-
mains on laminin that are able to promote the adhesion of
these cells.
Purification ofa3ß, Integrin
byAffinity Chromatography on
Peptide GD-6-Sepharose
As another means of showing that a3ß1 integrin binds to
laminin through the sequence of peptide GD-6, detergent ex-
tracts of surface-labeled cells were analyzed by affinity chro-
matography on peptide GD-6 coupled to Sepharose. C8161
human melanoma cells were selected since we have deter-
mined that they express relatively similar levels of many of
the known integrins (Seftor et al., 1992) . These cells wereFigure 4 . Integrin expression on C8161 cells . Detergent extracts
from surface labeled C8161 cells were immunoprecipitated with
anti-integrin mAbs to 012 (lane 1), ß, (lane 2), a 3 (lane 3), as
(lane 4), and a,. (lane 5) . Samples were analyzed by 7.5% SDS-
PAGE under nonreducing conditions, and autoradiographed as de-
scribed in Materials and Methods.
surface iodinated and proteins extracted with octylglucoside
as described in Materials and Methods. The extracts were
then immunoprecipitated with the antiintegrin subunit-
specific mAbs and thesehumanmelanoma cells were found
to express a,ß,, a2ß,, a3ß,, a5ß,, and a.-ß3 (Fig . 4) . Nota-
bly, the a,ß,, a 2ß,, a3ß,, and a6ß, integrins have been
shown to be laminin-binding integrins (Tomaselli et al.,
1990 ; Languino et al., 1989 ; Gehlsen et al., 1989 ; Sonnen-
berg et al., 1988) .
In parallel experiments, the radiolabeled cell extract was
passed over peptide affinity columns and bound proteins
were eluted with 20mM EDTA and analyzed by SDS-PAGE
under nonreducing conditions as described in Materials and
Methods (Fig. 5) . Two major proteins having apparent mo-
lecular sizes from 120 to 150kD bound to the peptide GD-6
affinity column (Fig . 5, lane 2) . In affinity chromatography
experiments using the RGD-containing peptide, KRGD,
only the aß3 integrin bound (Fig . 5, lane 3) as determined
by immunoprecipitation (data not shown) . Peptide F17
weakly bound proteins different from those seen with the
other peptide columns (Fig. 5, lane 4), whereas a mock-
coupled column and a control peptide column (SHGD-6)
bound no integrin-like cell surface proteins (Fig . 5, lanes 5
and 6, respectively) . Peptide GD-3 bound a 130-kD protein
that appears to be different than those proteins that bound to
the other peptide columns (Fig. 5, lane 1) . This 130-kD pro-
tein has been determined in preliminary immunoprecipita-
tion studies not to be a known integrin (data not shown), and
we are presently characterizing this protein by amino-
terminal amino acid sequencing . Several other control pep-
tides (SGD-6) and other laminin-derived peptides (GD-1,
GD-2, and AG-1) did not bind proteins related to integrins
using the above methods (data not shown) . These chroma-
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Figure 5. Affinity chromatography on peptide affinity columns . Ex-
tracts of radiolabeled C8161 human melanoma cells were passed
over various peptide-Sepharose columns . The EDTA eluted peak
fractions from the peptide columns are shown for peptide GD-3
(lane 1) ; peptide GD-6 (lane 2) ; KRGD (lane 3) ; peptide F17 (lane
4) ; a mock-coupled column (lane 5) ; and a control peptide, scram-
bled human GD-6 (SHGD-6, lane 6) . Samples were analyzed by
7.5 % SDS-PAGE under nonreducing conditions and autoradio-
graphed as described in Materials and Methods . Molecular sizes
are indicated .
tography experiments have been repeated numerous times
using different batches of peptides, including the human
GD-6 homologue (HGD-6), and different extracts of C8161
cells and other cell types, all with similar results .
The proteins that eluted from the GD-6 column with
EDTA were analyzed by immunoprecipitation using integrin
a- and 0-chain-specific mAbs . Only a3 and ß, integrin
subunits were immunoprecipitated from the peptide GD-6
column eluate (Fig. 6, lanes 3, 5, and 7) . The a-subunit la-
beled less well than the ß-subunit and are thus seen as faint
bands at the appropriate mobility. This trend is common for
iodination of integrin subunits . Neither protein was precipi-
tated with mAbs specific for a,, a2, C4, C15, U6, Cev, 02, or 03
integrin subunits.
Elution ofa3ß,from a Laminin-Sepharose Column by
Exogenous Peptide GD-6
The specificity of peptide GD-6 for a3ß, was also shown in
another experiment whereby a radiolabeled C8161 cell ex-
tract was passed over a human laminin-Sepharose column .
The column was washed with extraction buffer ; then 500
pg/ml ofpeptide GD-6 in extraction buffer was used to elute
bound material . Exogenous peptide GD-6 released virtually
453Figure 6. Immunoprecipitation analysis of proteins eluted from the
peptide GD-6 affinity column. The proteins eluted by EDTA from
the peptide GD-6 column were immunoprecipitated with antiinte-
grinmAbs . Peak fraction starting material is shown in lane 1 . Im-
munoprecipitation with anti-ß2 (lane 2) ; anti-ß1 (P4C10, lane 3) ;
anti-a2 (lane 4) ; anti-a3 (lane 5) ; anti-a4 (lane 6) ; and another
anti-ß, (mAb LM442, lane 7) . Immunocomplexes were separated
in a 7.5% SDS-PAGE and autoradiographed as described in
Materials and Methods.
all bound a3ß1 from the human laminin-Sepharose affinity
column (Fig . 7, lanes 8-13) . Subsequent elution of the lami-
nin column with 1 M NaCI released negligible amounts of
material (data not shown) . In a parallel experiment, exoge-
nous peptide GD-6 did not elute bound proteins from a
fibronectin fragment column (Fig . 7, lanes 1-6), although
subsequent elution of this column with 20 mM EDTA
released the expecteda5ß, integrin (Fig . 7, lane 7) as deter-
mined by immunoprecipitation analysis (data not shown) . In
a separate experiment, a3ß, that was bound to laminin-
Sepharose was eluted with 20 mM EDTA and the pooled
fractions were electrophoresed (Fig . 7, lane 14) to demon-
strate the specificity ofthehuman laminin column . Determi-
nation that only a3ß, bound to human laminin-Sepharose
was done by immunoprecipitation of the material shown in
lane 14 with various integrin-specific mAbs ; these results
have been previously reported elsewhere (Gehlsen et al .,
1989) . As a control, peptide KRGD did not elute a3ß1 from
the laminin-Sepharose column, but did elute a5ß, from the
fibronectin-Sepharose column . Also, peptide F17 did not
elute a3ß1 from the laminin-Sepharose column, even at a
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peptide concentration of 1 mg/ml . Furthermore, peptide
GD-3 and the scrambled version ofpeptide GD-6 (HSGD-6
and SGD-6) did not elute 01301 from the human lami-
nin-Sepharose column (data not shown) .
Inhibition ofCell Adhesion to Peptide GD-6 by
Antiintegiin Antibodies
As shown above, peptide GD-6 promoted the adhesion of
C8161 cells when adsorbed to microtiter wells (Fig . 2) .
The adhesion of C8161 cells to surfaces adsorbed with pep-
tide GD-6 was examined in the presence of various antiinte-
grin subunit-specific antibodies . Anti-a3 (PIB5) and anti-ß,
(P4C10) mAbs significantly inhibited cell adhesion to pep-
tide GD-6, whereas anti-a2, -a4, -a5 , -ab , -av , and -ß 2
mAbs had no inhibitory effect (Fig. 8) . As an additional con-
trol, the anti-as mAb did not block C8161 cell adhesion to
peptide KRGD-coated surfaces (data not shown) .
Inhibition ofLaminin-mediated CellAdhesion by
anti-GD-6 Antibodies
Additional evidence that the sequence of peptide GD-6 is an
important cell adhesion site in laminin was obtained by
generating polyclonal antisera against peptide GD-6. The an-
tisera was purified by ammonium sulfate precipitation and
DEAE-chromatography ; then the IgG was affinity purified
on an EHS-laminin-Sepharose column . This purified IgG
reacted specifically with peptide GD-6, murine laminin, and
the human laminin, but did not react with other peptides
(AS3) and proteins such as fibronectin or ovalbumin (Fig. 9) .
Furthermore, the anti-GD-6 IgG almost completely (88%)
inhibited C8161 cell adhesion to surfaces absorbed with pep-
tideGD-6 and significantly inhibited cell adhesion (60%) to
intact EHS-laminin or human laminin (Fig . 10), but not to
fibronectin . These results indicate that the site in laminin
represented by peptide GD-6 is accessible to IgG and cell
surface integrin receptors . These data support previous re-
ports which suggest that a3ß, binds to the carboxy-terminal
globular domain of laminin (Gehlsen et al ., 1989 ; Tomaselli
et al., 1990) and may also recognize additional sites within
this region . As a control, normal rabbit IgG did not inhibit
laminin- or peptide GD-6-mediated cell adhesion .
Discussion
We report herein on an amino acid sequence, KQNCLSSRA-
SFRGCVRNLRLSR, named GD-6, derived from the lami-
nin A chain carboxy terminus that represents a major site for
interaction with the a 3ß, integrin . The following data sug-
gest that this amino acid sequence is a major site for a3ß,
integrin binding to laminin . Peptide GD-6 can support the
adhesion ofmany cell typeswhen immobilized to microtiter
wells (Wilke and Skubitz, 1991 ; and our present work),
and can inhibit cell attachment in a concentration-depen-
dent manner to surfaces absorbed with either human or mu-
rine laminin . When various laminin-derived peptides were
screened by an in vitro a3ß, receptor binding assay, peptide
GD-6 supported the binding of purified a3ß, . Furthermore,
peptide GD-6-Sepharose specifically bound a 3ß1 from C8161
cell extracts in a cation-dependent fashion . In addition, pep-
tide GD-6 completely eluted a3ß1 from human laminin-
Sepharose, but did not cause the release ofthe a5ß, integrin
454Figure 7 . Elution ofa3ß1 from a laminin-Sepharose affinity column by peptide GD-6. Both fibronectin- and laminin-Sepharose columns
were eluted with 500pg/ml of peptide GD-6. Lanes1-6show the elution profilefrom the fibronectin column using peptideGD-6, followed
by an elution withEDTA (lane 7) . Lanes8-13 show the proteins eluted by peptide GD-6 from the laminin-Sepharose column . In a parallel
experiment, material eluted withEDTA from a separate laminin-Sepharose column is shown in lane 14. Fractions were electrophoresed
and autoradiographed as described above .
from fibronectin-Sepharose . Several control peptides, two
consisting ofpeptide GD-6 in a scrambled sequence (SGD-6
and HSGD-6), and several other laminin-derived peptides
having a similar basic charge, had no activity in any of the
assays described . Moreover, mAbs specific for (X3 or 01 in-
hibited cell adhesion to surfaces adsorbed with peptideGD-6.
Finally, antisera raised against peptide GD-6 bound to mu-
rineandhumanlamininand significantly blocked cell attach-
ment to both murine and human laminin. Taken together,
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Figure 8 . Inhibition ofcell adhesionto peptideGD-6 using antiinte-
grin antibodies . Cellswere incubated in peptideGD-6-coated wells
(1 pg/well) in the presence of various antfntegrin mAbs-anti-N2,
anti-ß 1 , anti-a2, anti-a3, anti-a4, anti-a s, and anti-as-at a con-
centration of5 Fag/ml for 1 h at 37°C. Control represents cell adhe-
sion in the absence ofmAbs . Data represent duplicate experiments
done in triplicate and the SD.
these results strongly suggest that the amino acid sequence
of peptide GD-6 represents at leastone binding site in lami-
nin for a3ß1 -
Peptide GD-6 has previously been shown to promote the
attachment of human keratinocytes (Wilke and Skubitz,
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Figure 9 Specificity ofrabbit polyclonal IgG against peptideGD-6 .
Microtiter wells were coated with peptides GD-6 and AS3 at 1
fcg/well, and with the proteins murine laminin (M-LM), human
laminin(H-LM), fibronectin (FN),andovalbumin(OA) at 3 pg/ml .
Peptide AS3 is a complementary peptide to F9 (Skubitz et al .,
1990) and is derived from laminin . ELISAs were performed using
100 ug/ml of affinity-purified IgG and the mean OD 490 nm is
shown for both theanti-GD-6 and normal rabbit sera. * represents
statistically significant bindingcompared to controls andother pro-
teins.IgG (ug/ml)
Figure 10. Inhibition of cell attachment by anti-GD-6 antibodies.
Microtiter wells were coated with either EHS-laminin (0.7 ug/ml,
m), human laminin (2 ug/ml, A), fibronectin (514g/ml, o), or pep-
tide GD-6 (0.8,ug/ml, e), and were incubated for 30 min with vari-
ous concentrations of affinity-purified antipeptide GD-6 IgG.
C8161 cells were then added to the wellsand incubated in the pres-
ence ofthe IgG for30 minat 37°C. Wells were washed and adherent
cellsquantitated. Thepercent inhibition of cell adhesion was deter-
minedas described in Materials and Methods. Background inhibi-
tion in the presence of normal rabbit IgG has been subtracted from
each value. Data represent three experiments done in triplicate.
1991) . In this study, we report that other cell types including
MG-63, C8161, and IMR-90 cells also adhere to peptide
GD-6. These cells have been well characterized with respect
to their integrin repertoire, and they all have been shown to
express the a3ß, integrin, and other laminin-binding inte-
grins on their surfaces (Gehlsen et al., 1989; Languino et
al., 1989). Human keratinocytes have also been shown to ex-
press a3ß,, and recently, epiligrin, a new potential ligand
for a3ß1 has been isolated from keratinocyte matrices
(Carter et al., 1991). However, further characterization of
epiligrin is required to determine if this molecule is related
to other matrix proteins that bind a3ß,.
Recently, there has been a discrepancy in the literature as
to whether or not a3ß1 is a true laminin receptor. Carter et
al. (1991) has suggested that a3ß1 is not a receptor for lami-
nin based on their inability to inhibit HT1080 cell adhesion
to EHS-laminin using the anti-013 mAb P1B5. However, ear-
lier reports by several groups have clearly shown that (X301
is indeed a laminin-binding integrin and that mAb P1B5
could, in fact, partially inhibit laminin-mediated cell adhe-
sion (Tomaselli et al., 1990; Gehlsen et al., 1988, 1989;
Carter et al., 1990). mAb P1B5 did not completely inhibit
laminin-mediated cell adhesion in our previous and present
studies, and the inability of this mAb to completely inhibit
cell adhesion to either peptide GD-6 or to laminin suggests
that the C8161 cells used in our studies may contain addi-
tional laminin receptor binding mechanisms. Alternatively,
it is possiblethat the epitope recognizedby this antibody may
not interfere with receptor-ligand interactions as well as
other known antiintegrin antibodies. Furthermore, it is con-
ceivable that this integrin may contain several interactive
regions for the different ligands or binding sitesthat it recog-
nizes and, therefore, this mAb may only partially blockone
such interaction.
Evidence that a3ß, can recognize several distinct sites
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within the ligands to which it binds was presented by Elices
et al. (1991), who showed that «3ß, could bind to fibronec-
tin-Sepharose in an RGD-dependent manner only after «,0,
was removed from the cell extracts. However, binding of
a3ß, to human laminin has been shown to be RGD-indepen-
dent (Gehlsen et al., 1988; Elices et al., 1991; Sonnenberg
et al., 1991) . 0001 was not elutable from human laminin-
Sepharose by RGD-containing peptides, nor did purified
a3ß, bind to RGD-coated surfaces. Therefore, it is not yet
clear which mechanism this receptor uses to bind to the RGD
site in fibronectin and yet apparently not bind to the RGD
site in laminin. In addition, Elices et al . (1991) showed that
a3ß, could be eluted from laminin and fibronectin-Sepharose
using high concentrations of NaCl, thus suggesting that both
cation-dependent and ionic interactions may function in
01301 binding to its ligands. We have preliminary evidence
that suggests that «3ß, may acquire a different binding state
following the receptor's binding to laminin, which might al-
low this receptor to remain bound to laminin even in the
presence of EDTA; but then can be eluted by 1 M NaCl
(Gehlsen, K. R., unpublished results). Several other inte-
grins including a2ß,, a4ß,, and «1n,ß3 also appear to recog-
nize distinct sites within the same or different ligands and
also may be able to alter their binding affinities after ligand
or antibody interactions (Elices and Hemler, 1989; Mould
et al ., 1991; Phillips et al., 1991) .
Peptide GD-6 contains two cysteine residues and thus it
was possible that the interaction of GD-6 with a3ß1 could
have been through free sulfhydryl groups. To exclude this
type of interaction we synthesized peptide GD-6 that had ei-
ther unmodified or blocked cysteines. The results for all
forms ofpeptide GD-6 were identical in the experiments de-
scribed herein. In addition, it is unlikely that EDTA would
have eluted this a3ß, receptor from a peptide GD-6-Seph-
arose column, ifthe interactions were due to disulfide bridg-
ing. Therefore, future studies will focus on determining the
mechanism by which certain integrins recognize multiple
ligands through apparently distinct sequences.
Exogenous peptide GD-6 was able to inhibit C8161 cell
adhesion to human laminin in a concentration-dependent
manner. This inability ofpeptide GD-6 to completely inhibit
cell attachment to human laminin is most likely due to the
presence of multiple cell binding sites on laginin and other
laminin binding receptors on the cells. It has previously been
shown that not only do integrins, such as «,0,, a2ß,, a3ß,,
a6ß,, «,0,, and aßß3 bind laminin, but also that other non-
integrin molecules bind laminin as well. There are reports
suggesting that cell surface heparin-like molecules or hepa-
ran sulfate proteoglycans can interact with specific regions
on laminin (Charonis et al., 1988 ; Skubitz et al., 1991) .
Other cell surface molecules also have been reported to bind
laminin including a 67-kD protein (Terranova et al., 1983)
and 01,4 galactosyltransferase (Begovac et al., 1991) . Re-
cently, Skubitz et al. (1991) has described several peptide se-
quences from the G domain of laminin that support cell
adhesion and inhibit laminin-mediated cell attachment. In-
terestingly, two of the reported peptides, GD-3 and GD-4,
were shown to possibly interact with the 01 integrin subunit
while peptides GD-1 and GD-2 bound heparin and may ad-
here to cells through proteoglycans. We have tested these
peptides in our assays and, as presented, when peptide GD-3
was coupled to Sepharose, the column bound a 130-kD pro-
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Figure 11. Comparison of the murine, human, and merosin GD-6
sequences. The aminoacid sequence for the murine-derived GD-6
peptide was compared to thesesequences found in the same regions
of the human laminin A chain and in the human merosin A chain.
Identical amino acid residues are boxed.
tein which did not immunoprecipitate with our anti-ß, anti-
body. However, it is possible that this protein may represent
a variant of the known ß, subunit, or it may be an as yet
uncharacterized integrin subunit. Further studies into the
specificities of the described globular domain peptides are
presently beingdone to resolve these issues. These data also
provide evidence suggesting that cellscontain several differ-
ent mechanisms for adhesion to laminin and to other base-
ment membrane proteins. Since multiple peptide sequences
derived from laminin have been reported (Grafet al., 1987;
Charonis et al ., 1988; Tashiro et al ., 1989; Skubitz et al.,
1991), the understanding that multiple mechanisms for lami-
nin interactions with cells becomes more likely.
It is now apparent that there are several distinct isoforms
of laminin (Sasaki et al., 1988; Olsen et al., 1989; Ehrig et
al., 1990; Sanes et al., 1990). Both murine EHS-laminin
and human forms of laminin support C8161 cell adhesion.
The GD-6 peptide sequence used in this study was derived
from the murine EHS-laminin sequence. To determine if the
human counterpart of peptide GD-6 would also bind a3ß,,
we synthesized the humanpeptide (HGD-6; Table I, Fig. 11) .
When peptide HGD-6 was used in parallel experiments with
peptide GD-6, the results of the direct cell adhesion, inhibi-
tion assays, and affinity chromatography assays, were identi-
cal to those presented herein for peptide GD-6. The homolo-
gous merosin sequence is also shown for comparison (Fig.
11). There is 64% identity between the murine laminin and
human laminin sequences, 45 % identity between merosin
and the murine laminin sequence, and 50% identity between
the human laminin and merosin sequences. Since a3ß, was
described as a receptor that binds to human placental-
derived forms oflaminin (Gehlsen et al ., 1988, 1989), it will
be important to test the various corresponding globular do-
main "GD" peptides derived from both merosin and human
laminin in order to determine if they also interact with inte-
grins.
The carboxy-terminal, or G domain, of the laminin A
chain has 5 looplike structures of ti 30 % identity (Deutz-
mann et al., 1988). The peptide GD-6 sequence of laminin
is located in the last looplike structure. Previous studies have
shown that 01301 binds to the pepsin fragment of human
laminin and also to the E8 fragment of murine laminin
(Gehlsen et al., 1989 ; Tomaselli et al., 1990). It has been
shown that the E8 fragment is comprised of the first-three
looplike structures of the G domain and is lacking the E3
fragment (the last two looplike structures), which contains
the sequence of peptide GD-6 (Deutzmann et al., 1988) . It
is possible that the murine laminin E8 preparations contain
additional sites that could support a3ß, binding, or that the
preparations are not completelypure since elastase digestion
may be incomplete, resulting in parts ofthe last two loop-like
structures being present in the E8 preparations. Alterna-
tively, sites similar to the peptide GD-6 sequence may exist
within the first three looplike structures of murine laminin
and evidence for such sitesis seen when comparing,the GD-6
sequence with the GD-1 sequence. There is a stretch of five
amino acids that are nearly identical (SFRGC) and these se-
quences also contain similar regions of charge distribution.
Peptide GD-1 has also been shown to support cell adhesion
(Skubitz et al., 1991). Future experiments will determine if
such similar sequences are important for integrin binding.
Thus, the similarities among these looplike structures may
provide for additional receptor binding sites and that in the
intact forms of laminin, the GD-6 site is possibly a major
site for the binding of the 0001 integrin .
The G domain not only binds a3ß,, as previously shown
(Gehlsen et al., 1989; Tomaselli et al., 1990), but also sup-
ports the binding of a6ß, (Sonnenberg et al., 1990, 1991) .
Recently, it has been reported that a6ß, binds to both the
murine laminin E8 fragment and the human laminin pepsin
fragment (Sonnenberg et al., 1991). However, when cells
were used that contain both 0130, and a6ß,, it was necessary
to first remove the a3ß, from the detergent cell extracts be-
fore a6ß, binding to human laminin could be detected.
These results support the present study, such that the murine
E8 fragment may not contain the GD-6 sequence and this
might explain why a3ß, binds less well to this fragment
than does a6,ß,. This study also presents data showing that
a3ß, binds to human laminin with a much higher affinity
than does a6ß, . This result might suggest that the human
laminin used in our studies may contain the GD-6 site,
whereas, the murine E8 fragment does not contain this site.
Support for this conclusion is derived from the fact that the
anti-GD-6 antisera reacts with our human laminin prepara-
tions. These results, taken together, suggest that the GD-6
sequence may be the primary laminin binding site for a3ß,,
and that there may also exist yet other interactive sites for
this receptor. The consequences of having multiple sites in
laminin for receptor interaction may allow for an increased
cell binding affinity. In addition, having multiple receptor
binding sitesand receptors creates the possibility for a diver-
sity of laminin-mediated effects on cellular behavior. Such
regulation of cellular responses may relate to the type and
number of specific laminin-binding receptors expressed on
a cell surface.
It now appears that not only can integrins distinguish be-
tween specific regions of laminin, but there is evidence that
certain integrins can recognize different species homologues
of laminin as well (Brown and Goodman, 1991; Goodman
et al., 1991). For example, there is data to suggest that the
a3ß, integrin on human cells has a higher affinity for hu-
man forms of laminin compared with the binding of a6ß,,
whereas a6ß, from human cells and platelets binds prefer-
entially to EHS-laminin (Sonnenberg et al ., 1991) . Further-
more, a3ß, has not been observed in cell-substratum adhe-
sion plaques when human cellsare plated on murine laminin
(Carter et al., 1990; Sonnenberg et al., 1991), but can
clearly be seen when humancellsare seeded on humanlami-
nin (Gehlsen, K. R., unpublished results). These data sug-
gest that a3ß, and a6ß, may have different affinities for
different laminins due to specific species differences found
457within the binding sequences. Therefore, future experiments
to determine if a6 ß, and «3181 share common binding sites
within laminin need to be done.
In conclusion, the data presented strongly suggest that the
amino acid sequence of peptide GD-6 represents at least one
site in laminin for binding of the a3ß1 integrin. Identifica-
tion of this and other integrin-binding sites in laminin will
help in our understanding of laminin-mediated regulation of
cellular function.
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